Skip to content

Effectiveness of a Mobile Health Management Program for Colorectal Cancer Survivors with Chronic Conditions

A Randomized Controlled Clinical Study for Validating the Effectiveness of a Mobile Health Management Program Aimed At Colorectal Cancer Survivors with Comorbid Chronic Conditions

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06759844
Enrollment
200
Registered
2025-01-06
Start date
2025-01-01
Completion date
2025-12-31
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Colo-rectal Cancer, Hypertension, Dyslipidemia

Brief summary

The goal of this clinical trial is to evaluate if a mobile health management program can improve chronic disease management among colorectal cancer survivors with comorbid conditions such as hypertension, diabetes, and dyslipidemia. The main questions it aims to answer are: Does the mobile health application improve clinical outcomes such as blood pressure, blood glucose levels, and lipid profiles? Does the application enhance participants' health behaviors and self-management capabilities? Researchers will compare the mobile health application group to the educational booklet group to see if the digital intervention leads to better health outcomes and adherence to lifestyle changes

Interventions

A printed booklet containing general information on chronic disease management provided to participants for reference without interactive or digital features

A mobile health application that facilitates self-management of chronic conditions through daily education, personalized goal setting, and lifestyle monitoring. The intervention aims to improve participants' health behaviors and clinical outcomes by promoting active engagement with their health.

Sponsors

National Cancer Center, Korea
CollaboratorOTHER_GOV
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This study is a randomized controlled trial evaluating the effectiveness of a mobile health application in colorectal cancer survivors with chronic conditions. The study does not involve any drug, biological product, or combination product.

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals aged 19 years or older Colorectal cancer survivors (patients within 5 years of completion of curative treatments such as surgery, radiation therapy, or chemotherapy) who also have chronic conditions (hypertension, dyslipidemia, or diabetes) Specific registration criteria: Diabetes: Fasting blood sugar (FBS) ≥ 126 mg/dL or HbA1c ≥ 6.5% Dyslipidemia: Low-density lipoprotein cholesterol (LDL) ≥ 130 mg/dL Hypertension: Systolic blood pressure (SBP) ≥ 140 mmHg or Diastolic blood pressure (DBP) ≥ 90 mmHg Individuals who understand the purpose of this study and provide informed consent to participate Individuals who own and use a smartphone (able to use an ICT-based health management program)

Exclusion criteria

* Individuals who are unable to speak, listen, or read in Korean Individuals determined by a physician to be physically or mentally unfit (e.g., shortness of breath, severe depression) to participate in the study Individuals who are deemed unable to use the ICT-based program

Design outcomes

Primary

MeasureTime frameDescription
Physical Activity LevelsFrom enrollment to the end of treatment at 3monthsCheck if the level has decreased
Systolic and Diastolic Blood PressureFrom enrollment to the end of treatment at 3monthsCheck if the level has decreased
Body WeightFrom enrollment to the end of treatment at 3monthsCheck if the level has decreased
Body Mass IndexFrom enrollment to the end of treatment at 3monthsCheck if the level has decreased
Fasting Blood SugarFrom enrollment to the end of treatment at 3monthsCheck for decreased blood sugar levels
Hemoglobin A1cFrom enrollment to the end of treatment at 3monthscheck if the level has decreased
Total CholesterolFrom enrollment to the end of treatment at 3monthsCheck if the level has decreased
LDL CholesterolFrom enrollment to the end of treatment at 3monthsCheck if the level has decreased

Secondary

MeasureTime frameDescription
Increase in Health Behavior PatternsFrom enrollment to the end of treatment at 3monthsDifferences in Questionnaire of Health Behavior and Practice Index
Emotional and Subjective Health StatusFrom enrollment to the end of treatment at 3monthsDifferences in Questionnaire of Patient Health Questionnaire-9
Improvement in Health Management CapabilityFrom enrollment to the end of treatment at 3monthsDifferences in Questionnaire of Self-Assessment Tool

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026